Development and validation of an optimized prediction of mortality for candidates awaiting liver transplantation.

ethics and public policy liver transplantation/hepatology liver transplantation: auxiliary simulation statistics

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
04 2019
Historique:
received: 18 06 2018
revised: 04 10 2018
accepted: 22 10 2018
pubmed: 10 11 2018
medline: 22 7 2020
entrez: 10 11 2018
Statut: ppublish

Résumé

Since 2002, the Model for End-Stage Liver Disease (MELD) has been used to rank liver transplant candidates. However, despite numerous revisions, MELD allocation still does not allow for equitable access to all waitlisted candidates. An optimized prediction of mortality (OPOM) was developed (http://www.opom.online) utilizing machine-learning optimal classification tree models trained to predict a candidate's 3-month waitlist mortality or removal utilizing the Standard Transplant Analysis and Research (STAR) dataset. The Liver Simulated Allocation Model (LSAM) was then used to compare OPOM to MELD-based allocation. Out-of-sample area under the curve (AUC) was also calculated for candidate groups of increasing disease severity. OPOM allocation, when compared to MELD, reduced mortality on average by 417.96 (406.8-428.4) deaths every year in LSAM analysis. Improved survival was noted across all candidate demographics, diagnoses, and geographic regions. OPOM delivered a substantially higher AUC across all disease severity groups. OPOM more accurately and objectively prioritizes candidates for liver transplantation based on disease severity, allowing for more equitable allocation of livers with a resultant significant number of additional lives saved every year. These data demonstrate the potential of machine learning technology to help guide clinical practice, and potentially guide national policy.

Identifiants

pubmed: 30411495
doi: 10.1111/ajt.15172
pii: S1600-6135(22)09033-5
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1109-1118

Informations de copyright

© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Auteurs

Dimitris Bertsimas (D)

Operations Research Center, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Jerry Kung (J)

Operations Research Center, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Nikolaos Trichakis (N)

Operations Research Center, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Yuchen Wang (Y)

Operations Research Center, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Ryutaro Hirose (R)

Department of Surgery, University of California, San Francisco, California.

Parsia A Vagefi (PA)

Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH